Report from Thailand - The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness. - BioPharm International

ADVERTISEMENT

Report from Thailand
The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.


BioPharm International
Volume 26, Issue 4, pp. 8-9

IMPORTANT FACTS

  • Under Thailand's first National Biotechnology Policy Framework (2004 to 2009), 90 new companies were formed, bringing the number of biotech companies to an estimated total of 170.
  • Thailand has succeeded in producing the world's first commercial biosensor for avian influenza. Currently, it is in the process of producing its first indigenous drug to treat malaria. If successful, it will be a breakthrough development that puts Thailand on the world map.
  • Thailand is regarded as a prime "pharmerging market" due to the potential of its biotech sector. The large population and academic/healthcare infrastructure make the country an ideal provider of clinical trials.

—Jane Wan is a freelance writer based in Singapore.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here